DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» GC376
GC376
Researchers Pinpoint Promising Inhibitors That Could Lead to New Antiviral Drugs to Treat COVID-19 10 August 2021, by Erin Matthewserin Matthews
Structure Basis for Inhibition of SARS-Cov-2 by the Feline Drug GC376
Hepatitis C Virus Drugs Simeprevir and Grazoprevir Synergize With
Potential in Vitro Inhibition of Selected Plant Extracts Against SARS-Cov-2 Chymotripsin-Like Protease (3Clpro) Activity
Challenges for Targeting SARS-Cov-2 Proteases As a Therapeutic Strategy for COVID-19
Efficacy of a 3C-Like Protease Inhibitor in Treating Various Forms of Acquired
Original Article Structural Basis of SARS-Cov-2 Main Protease Inhibition by a Broad-Spectrum Anti-Coronaviral Drug
Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-Cov-2 3Clpro Inhibitors
Progress in Developing Inhibitors of SARS-Cov-2 3C-Like Protease
Identification of SARS-Cov-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
Insights Into SARS-Cov-2
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity 2 3 Samuel J
Consumption of Phenolic-Rich Food and Dietary Supplements As a Key Tool in SARS-Cov-19 Infection
3C-Like Protease Inhibitors Against Coronaviruses by Krishani Dinali
Original Article Tannic Acid Suppresses SARS-Cov-2 As a Dual Inhibitor of the Viral Main Protease and the Cellular TMPRSS2 Protease
Rational Design of a New Class of Protease Inhibitors for the Potential Treatment of Coronavirus Diseases
Boceprevir, GC-376, and Calpain Inhibitors II, XII Inhibit SARS-Cov-2 Viral Replication by Targeting the Viral Main Protease
Both Baicalein and Gallocatechin Gallate E Caciously Inhibit SARS
Top View
Screening for Inhibitors of Main Protease in SARS-Cov-2: in Silico and in Vitro Approach Avoiding Secondary Amides
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Non-Specific
Characterization of Amino Acid Substitutions in Feline Coronavirus
Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs Against SARS-Cov-2
Feline Coronavirus Drug Inhibits the Main Protease of SARS-Cov-2 and Blocks Virus Replication
Animal Coronavirus Diseases: Parallels with COVID-19 in Humans
Both Boceprevir and GC376 Efficaciously Inhibit SARS-Cov-2 By
Boceprevir, GC-376, and Calpain Inhibitors II, XII Inhibit SARS-Cov-2 Viral Replication by Targeting the Viral Main Protease
Programand ABSTRACTS
Targeting SARS‐Cov‐2 Viral Proteases As A
GC376 | Medchemexpress
Postinfection Treatment with a Protease Inhibitor Increases Survival of Mice with a Fatal SARS-Cov-2 Infection